Lowe Brockenbrough & Co Inc
- SEC CIK
- 0000022657
- Latest filing
- Aug 3, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Lowe Brockenbrough & Co Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 39,850
- Value
- $3.62M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 39,850 | $3.62M | 0.2% | −1,289−3.1% | Reduced | Holders |
| Q1 2026 | 41,139 | $4.22M | 0.2% | −818−1.9% | Reduced | Holders |
| Q4 2025 | 41,957 | $5.26M | 0.3% | −656−1.5% | Reduced | Holders |
| Q3 2025 | 42,613 | $5.71M | 0.3% | −180.0% | Reduced | Holders |
| Q2 2025 | 42,631 | $5.80M | 0.3% | +718+1.7% | Added | Holders |
| Q1 2025 | 41,913 | $5.56M | 0.4% | −881−2.1% | Reduced | Holders |
| Q4 2024 | 42,794 | $4.84M | 0.3% | −820−1.9% | Reduced | Holders |
| Q3 2024 | 43,614 | $4.97M | 0.3% | +1,616+3.8% | Added | Holders |
| Q2 2024 | 41,998 | $4.36M | 0.3% | −1,256−2.9% | Reduced | Holders |
| Q1 2024 | 43,254 | $4.92M | 0.3% | −3,730−7.9% | Reduced | Holders |
| Q4 2023 | 46,984 | $5.17M | 0.4% | −206−0.4% | Reduced | Holders |
| Q3 2023 | 47,190 | $4.57M | 0.4% | −4,886−9.4% | Reduced | Holders |
| Q2 2023 | 52,076 | $5.68M | 0.4% | −347−0.7% | Reduced | Holders |
| Q1 2023 | 52,423 | $5.31M | 0.4% | +2,152+4.3% | Added | Holders |
| Q4 2022 | 50,271 | $5.52M | 0.5% | −2,001−3.8% | Reduced | Holders |
| Q3 2022 | 52,272 | $5.06M | 0.5% | −351−0.7% | Reduced | Holders |
| Q2 2022 | 52,623 | $5.72M | 0.5% | −2,613−4.7% | Reduced | Holders |
| Q1 2022 | 55,236 | $6.54M | 0.5% | −2,797−4.8% | Reduced | Holders |
| Q4 2021 | 58,033 | $8.17M | 0.6% | −847−1.4% | Reduced | Holders |
| Q3 2021 | 58,880 | $6.96M | 0.5% | +991+1.7% | Added | Holders |
| Q2 2021 | 57,889 | $6.71M | 0.6% | +4,804+9.0% | Added | Holders |
| Q1 2021 | 53,085 | $6.36M | 0.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.